- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Triage using coronary CTA permits early discharge from ER
Results of a three-year trial at Massachusetts General Hospital show that half of patients presenting with chest pain but at low or intermediate risk of acute coronary syndrome can be safely discharged following a negative 64-slice coronary CT evaluation.
Results of a three-year trial at Massachusetts General Hospital show that half of patients presenting with chest pain but at low or intermediate risk of acute coronary syndrome can be safely discharged following a negative 64-slice coronary CT evaluation.
The Rule-out Myocardial Infarction Using Computer-Assisted Tomography (ROMICAT) study prospectively evaluated 368 patients who underwent contrast-enhanced 64-slice coronary CT angiography after the determination of low or intermediate risk of ACS upon arrival in the emergency room of the Heart Center at MGH. Imaging investigated patients' coronary arteries for the presence of atherosclerotic plaque and significant (>50%) arterial stenosis.
Dr. Fabian Bamberg, an instructor in radiology in the MGH cardiac MR PET/CT program, reported Sunday at the 2008 RSNA meeting that nearly half of the patients had neither plaque nor stenosis. No patient with a negative coronary CTA assessment had a major coronary event in the six months after imaging, producing a negative predictive value of 100%.
Significant stenosis was identified in 18.4% of the patients, a finding that equated with more than an 11-fold increased risk of ACS, Bamberg said.
ROMICAT is the largest single-center trial to date to examine the feasibility of coronary CT to rule out acute coronary syndrome in the emergency room, Bamberg said. Studies presented in previous years at the RSNA conference were typically limited to about 100 patients.
"Our triage criteria really permit a safe discharge home," Bamberg said in an interview. "Patients are not required to be admitted to the hospital. They can be discharged right away."
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
